O'Connor Alternative Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

O'Connor Alternative Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,867,553	Closed	-$40M	–	165
2026 Q1	$40M	Buy	+1,867,553	New	+$26.3M	2.1%	10

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

O'Connor Alternative Investments's DAWN Position: Q2 2026 in Review

O'Connor Alternative Investments sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,867,553 shares — an estimated $40M sold.

O'Connor Alternative Investments first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $40M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

O'Connor Alternative Investments reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
O'Connor Alternative Investments sold 1,867,553 Day One Biopharmaceuticals shares in Q2 2026, an estimated $40M.
O'Connor Alternative Investments first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
O'Connor Alternative Investments's Day One Biopharmaceuticals position peaked at $40M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on O'Connor Alternative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.